Turn Therapeutics (TTRX) Payables (2025 - 2026)
Turn Therapeutics (TTRX) posted quarterly Payables of $2.8 million for Q1 2026, down 8.62% quarter-over-quarter from $3.0 million in Q4 2025.
Analysis
Turn Therapeutics (TTRX) Payables (2025 - 2026) Analysis & Trends
Turn Therapeutics' Payables history runs 2 years deep, the most recent figure standing at $2.8 million for Q1 2026.
- In Q1 2026, Payables changed N/A year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $2.8 million (changed N/A YoY), while the FY2025 annual figure was $3.0 million, changed N/A from the prior year.
- Payables for Q1 2026 stood at $2.8 million, down from $3.0 million in the prior quarter.
- The five-year high for Payables was $3.0 million in Q4 2025, with the low at $2.8 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 167.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 88.42 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 470.30 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 108.02 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 35.57 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Turn Therapeutics | 302.05 Mn | 302.05 Mn | - | 6.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.11 Mn |
| Mar 31, 2026 | 2.77 Mn |
| Dec 31, 2025 | 3.03 Mn |